PGNY - CIK 0001551306
Progyny, Inc. trades as PGNY and has a market capitalization of $2.02 B, making it the #2093 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.29B, up 10.4% from the prior year and net income of $58.52M. This page tracks Progyny, Inc. through 893 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 5 fiscal years Progyny, Inc.'s revenue grew from $344.86M to $1.29B, a compound annual growth rate of 30.2%. Net profit margin compressed from 13.5% to 4.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-27 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | Progyny, Inc.
Progyny, Inc. Announces Share Repurchase Program | Progyny, Inc.
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference | Progyny, Inc.
Progyny, Inc. Announces First Quarter 2026 Results | Progyny, Inc.
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report | Progyny, Inc.
The largest companies sharing Progyny, Inc.'s SEC industry classification (services-misc health & allied services, nec).
Progyny, Inc. (PGNY) has a market capitalization of $2.02 B as of 2026-06-10, ranking #2093 among US-listed companies.
Progyny, Inc. reported revenue of $1.29B for fiscal year 2025, an increase of 10.4% year over year.
Yes. Progyny, Inc. reported net income of $58.52M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.